- Brain research, antimicrobial resistance among Obama FY15 priorities
- Industry scrambles to defuse row over "satanic" campaign against South African IP plans
- US Capitol Capsule: Transferable market exclusivity: Antibiotics savior?
- US Capitol Capsule: Rare disease sector matures; FDA keeping pace?
COMMENT Other Informa Comment
- INTERVIEW: Johnson & Johnson Innovation's J-Labs seeks out new ideas in Texas
- Profile: The ABPI's reimbursement director on Pfizer, his TicTac salary, and paper mache